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ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) nsp1 sup-
presses host gene expression in expressed cells by inhibiting translation and induc-
ing endonucleolytic cleavage of host mRNAs, the latter of which leads to mRNA de-
cay. We examined the biological functions of nsp1 in infected cells and its role in
virus replication by using wild-type MERS-CoV and two mutant viruses with specific
mutations in the nsp1; one mutant lacked both biological functions, while the other
lacked the RNA cleavage function but retained the translation inhibition function. In
Vero cells, all three viruses replicated efficiently with similar replication kinetics,
while wild-type virus induced stronger host translational suppression and host
mRNA degradation than the mutants, demonstrating that nsp1 suppressed host
gene expression in infected cells. The mutant viruses replicated less efficiently than
wild-type virus in Huh-7 cells, HeLa-derived cells, and 293-derived cells, the latter
two of which stably expressed a viral receptor protein. In 293-derived cells, the three
viruses accumulated similar levels of nsp1 and major viral structural proteins and did
not induce IFN- and IFN- mRNAs; however, both mutants were unable to generate
intracellular virus particles as efficiently as wild-type virus, leading to inefficient pro-
duction of infectious viruses. These data strongly suggest that the endonucleolytic
RNA cleavage function of the nsp1 promoted MERS-CoV assembly and/or budding
in a 293-derived cell line. MERS-CoV nsp1 represents the first CoV gene 1 protein
that plays an important role in virus assembly/budding and is the first identified vi-
ral protein whose RNA cleavage-inducing function promotes virus assembly/bud-
ding.
IMPORTANCE MERS-CoV represents a high public health threat. Because CoV nsp1
is a major viral virulence factor, uncovering the biological functions of MERS-CoV
nsp1 could contribute to our understanding of MERS-CoV pathogenicity and spur
development of medical countermeasures. Expressed MERS-CoV nsp1 suppresses
host gene expression, but its biological functions for virus replication and effects on
host gene expression in infected cells are largely unexplored. We found that nsp1
suppressed host gene expression in infected cells. Our data further demonstrated
that nsp1, which was not detected in virus particles, promoted virus assembly or
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Middle East respiratory syndrome (MERS) is a viral respiratory illness caused byMERS coronavirus (MERS-CoV), which was first identified in Saudi Arabia in 2012
budding in a 293-derived cell line, leading to efficient virus replication. These data 
suggest that nsp1 plays an important role in MERS-CoV replication and possibly af-
fects virus-induced diseases by promoting virus particle production in infected hosts. 
Our data, which uncovered an unexpected novel biological function of nsp1 in virus 
replication, contribute to further understanding of the MERS-CoV replication strate-
gies.
KEYWORDS MERS coronavirus, nsp1, virus assembly/budding
(1). MERS outbreaks continue with increasing geographical distribution (2), and the 
mortality rate of MERS is approximately 36% (http://www.who.int/emergencies/mers 
-cov/en/). MERS-CoV represents a high public health threat, yet no vaccine or specific 
treatment for MERS is currently available.
CoVs belong to the order Nidovirales in the family Coronaviridae, and are currently 
classified into four genera, alpha, beta, gamma, and delta CoVs. CoV is an enveloped 
virus carrying a large single-stranded, nonsegmented RNA with the 5= end capped and 
the 3= end polyadenylated (3–5). Replication of MERS-CoV, a beta CoV, starts with 
binding of the virus particle to a receptor, dipeptidyl peptidase 4 (6), which is also called 
CD26. After virus-host membrane fusion (7), the viral genomic RNA is released into the 
cytoplasm and undergoes translation of partially overlapping two large precursor 
polyproteins from gene 1, which encompasses the 5= two-thirds of the genome. These 
precursor polyproteins are proteolytically processed by two virally encoded proteinases 
to generate 16 mature proteins, nonstructural protein 1 (nsp1) to nsp16 (8). All of these 
gene 1 proteins, except for nsp1 (9) and nsp2 (10), are considered to be essential for 
CoV RNA synthesis (11). MERS-CoV replication results in accumulation of eight viral 
mRNAs, including mRNA 1, the intracellular forms of viral genome, and subgenomic 
mRNAs 2 to 8 (12, 13); these viral mRNAs form the 3=-coterminal nested structure, and 
all carry the same leader sequence of 70 nucleotides at the 5= end (14–16). Viral 
structural proteins (S, E, M, and N proteins) and four accessory proteins (3, 4a, 4b, and 
5 proteins) are translated from these subgenomic mRNAs. MERS-CoV accessory proteins 
are not essential for virus replication, and yet they affect viral pathogenicity (17–19). 
Accumulation of viral proteins and mRNA 1 leads to the assembly of virus particles and 
budding of virus particles at endoplasmic reticulum Golgi intermediate compartment 
(ERGIC) membranes (20–22), followed by subsequent release of the virus from the cells. 
CoV M protein plays a central role in virus assembly (23–29). In many CoVs, including 
MERS-CoV, E protein, a low-abundance protein in the virus particle, is essential for 
production of infectious virus particles (23, 30–32), while severe acute respiratory 
syndrome CoV (SARS-CoV) mutant lacking E protein is viable but attenuated in growth 
(33).
Among the four CoV genera, only alpha and beta CoVs encode nsp1 (34). In contrast 
to nsp3 to nsp16 that play essential roles in exert viral RNA synthesis, nsp1 shares low 
amino acid homology among CoVs (35–39), and the sizes of beta CoV nsp1 and alpha 
CoV nsp1 differ; the former and the latter were 28 and 9 kDa, respectively. 
Nonetheless, structural analysis suggests that CoV nsp1 has a common origin (36) and 
that the nsp1s of alpha and beta CoVs share a biological function to inhibit host gene 
expression. Past studies suggest that mechanisms of host gene expression suppression 
induced by nsp1 of each CoV species may differ (39–43). Among CoV nsp1s, mecha-
nisms of nsp1-induced host gene suppression have been well characterized in severe 
respiratory syndrome CoV (SARS-CoV) nsp1. SARS-CoV nsp1 is a cytoplasmic protein 
that binds to the 40S ribosomal subunit (40, 41) and inactivates its translation function, 
which leads to translation inhibition. The SARS-CoV nsp1-40S ribosome complex also 
induces endonucleolytic cleavage of host mRNAs. Host 5=-3= exonuclease, Xrn 1, further 
degrades host mRNAs that undergo the nsp1-induced RNA cleavage (44). Although 
nsp1 suppresses translation of SARS-CoV mRNAs, it does not induce endonucleolytic
cleavage of SARS-CoV mRNAs (45). Like SARS-CoV nsp1, expressed MERS-CoV nsp1 
suppresses translation and induces endonucleolytic RNA cleavage of host mRNA, 
leading to host mRNA decay (43). However, unlike SARS-CoV nsp1, MERS-CoV nsp1 
localized in both the cytoplasm and nucleus, does not bind to 40S ribosomes, and 
targets host mRNAs of the nuclear origin, but not mRNAs of cytoplasmic origin (43). 
Several lines of evidence point toward the strong possibility that nsp1 is a major 
virulence factor of CoVs. SARS-CoV nsp1 suppresses the host innate immune functions 
by inhibiting interferon (IFN) expression (46) and host antiviral signaling pathways in 
infected cells (47). The nsp1 of porcine epidemic diarrhea virus suppresses type II IFN 
(48). The contribution of nsp1 in CoV pathogenesis has been demonstrated for mouse 
hepatitis virus and SARS-CoV (49–51).
Although it has been considered that nsp1 is not essential for CoV RNA synthesis (9), 
the biological roles of nsp1 in CoV replication are not well understood (39–41, 46, 52, 
53). Our present study demonstrated that, as in expressed cells, MERS-CoV nsp1 
suppressed host gene expression in infected cells. Unexpectedly, our studies revealed 
that the RNA cleavage function of the MERS-CoV nsp1 promoted virus assembly or 
budding in a 293-derived cell line. To our knowledge, MERS-CoV nsp1 is the first 
recognized CoV gene 1 protein that plays an important role in the production of 
infectious virus particles. Furthermore, MERS-CoV nsp1 is the first viral protein whose 
RNA cleavage-inducing function promoted the assembly/budding of virus particles.
RESULTS
Generation of MERS-CoV nsp1 mutants lacking host gene suppression func-
tions. Toward understanding the roles of MERS-CoV nsp1 in host gene expression and 
virus replication, we aimed to generate a MERS-CoV nsp1 mutant that lacks both host 
mRNA cleavage and host mRNA translation inhibition functions. Because the alanine 
substitutions of two charged amino acid residues, K164 and H165, of the 180-amino-
acid-long SARS-CoV nsp1 abolish translation inhibition function and the endonucleo-
lytic RNA cleavage function (46), we hypothesized that alanine substitution of a 
charged amino acid residue(s) near the C-terminal region of MERS-CoV nsp1 (193 amino 
acids) would also disrupt the MERS-CoV nsp1’s host gene suppression functions. Since 
alignment of amino acid sequences of MERS-CoV nsp1 and SARS-CoV nsp1 showed that 
K181 of MERS-CoV nsp1 corresponded to K164 of SARS-CoV nsp1, we hypothesized that 
K181A mutation in MERS-CoV nsp1 would disrupt the host gene suppression functions 
and constructed a T7 plasmid that expressed transcripts encoding MERS-CoV nsp1 with 
K181A mutation (MERS-CoV nsp1-mt).
To investigate the biological functions of MERS-CoV nsp1-mt, we independently 
transfected 293 cells with capped and polyadenylated RNA transcripts encoding chlor-
amphenicol acetyltransferase (CAT), SARS-CoV nsp1, wild-type MERS-CoV nsp1 (MERS-
CoV nsp1-WT), MERS-CoV nsp1-mt, and MERS-CoV nsp1 mutant carrying R125A and 
K126A mutation (MERS-CoV nsp1-CD), the latter of which lacks the endonucleolytic 
RNA cleavage activity but retains the translation suppression function (43). All encoded 
proteins carried a C-terminal myc tag. The cells were radiolabeled with Tran35S-label 
from 8.5 to 9.5 h after transfection, and cell extracts were subjected to SDS-PAGE 
analysis. Consistent with our previous reports (43, 46), expression of SARS-CoV nsp1, 
MERS-CoV nsp1-WT, and MERS-CoV nsp1-CD suppressed host protein synthesis (Fig. 1A, 
top two panels). In contrast, MERS-CoV nsp1-mt protein expression did not inhibit host 
protein synthesis. We also confirmed the expression of CAT, SARS-CoV nsp1, MERS-CoV 
nsp1-WT, MERS-CoV nsp1-CD, and MERS-CoV nsp1-mt (Fig. 1A, bottom two panels).
Next, we tested the effect of MERS-CoV nsp1-mt expression on abundance of a host 
mRNA. First, 293 cells were transfected with the RNA transcripts as described above. 
Intracellular RNAs were extracted at 9 h posttransfection and subjected to Northern 
blot analysis using a probe detecting glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNA (Fig. 1B). Reduction of GAPDH mRNA abundance occurred in cells 
expressing SARS-CoV nsp1 or MERS-CoV nsp1-WT, but not in those expressing MERS-
CoV nsp1-CD or CAT (43). MERS-CoV nsp1-mt expression also did not induce reduction
FIG 1 Characterization of the loss-of-function mutant, MERS-CoV nsp1-mt, in expressed cells. (A) 293 cells 
were transfected with 2 g of capped and polyadenylated RNA transcripts encoding CAT, SARS-CoV 
nsp1, MERS-CoV nsp1-WT, MERS-CoV nsp1-CD, or MERS-CoV nsp1-mt, all of which carried a C-terminal 
myc epitope tag, radiolabeled with Tran35S-label from 8.5 to 9.5 h posttransfection. Lysates were resolved 
using SDS–12% PAGE, followed by autoradiography (top panel), colloidal Coomassie blue staining 
(middle panel), and Western blot analysis with anti-myc and tubulin antibodies (bottom two panels). (B) 
293 cells were transfected with RNA transcripts as described in panel A. Intracellular RNAs were extracted 
at 9 h posttransfection and subjected to Northern blot analysis using a probe for GAPDH mRNA (top). The 
28S and 18S rRNAs were detected by ethidium bromide staining (bottom). (C) A schematic diagram of 
Ren-EMCV-FF is shown at the top of the panel. 293 cells were cotransfected with a plasmid encoding 
Ren-EMCV-FF and the plasmid expressing CAT, SARS-CoV nsp1, MERS-CoV nsp1-WT, MERS-CoV nsp1-CD, 
or MERS-CoV nsp1-mt protein; all nsp1s carried the C-terminal myc tag. At 24 h posttransfection, 
intracellular RNAs were extracted and subjected to Northern blot analysis using an RNA probe that binds 
to the rLuc gene (second panel). Arrowhead, full-length Ren-EMCV-FF; arrow, cleaved RNA fragment. The 
28S and 18S rRNAs were detected by ethidium bromide staining (third panel). Cell extracts, prepared at 
24 h posttransfection, were used for Western blot analysis using anti-myc and tubulin antibodies (fourth 
and fifth panels).
in the abundance of GAPDH mRNA, suggesting that MERS-CoV-mt did not induce the
endonucleolytic RNA cleavage to GAPDH mRNA and subsequent mRNA degradation.
To establish that MERS-CoV nsp1-mt lacks the endonucleolytic RNA cleavage func-
tion, 293 cells were transfected with a plasmid encoding CAT, MERS-CoV nsp1-WT,
MERS-CoV nsp1-CD, or MERS-CoV nsp1-mt, together with a plasmid encoding a bicis-
tronic reporter mRNA (Ren-EMCV-FF RNA) carrying the encephalomyocarditis virus
internal ribosomal entry sites (EMCV IRES) between the upstream Renilla luciferase
(rLuc) gene and the downstream firefly luciferase (fLuc) gene (Fig. 1C, top panel); all
expressed proteins carried a C-terminal myc tag. SARS-CoV nsp1 and MERS-CoV
nsp1-WT served as positive controls as they induce endonucleolytic RNA cleavage 
within the EMCV IRES region of Ren-EMCV-FF RNA (40, 43, 45), while CAT and MERS-CoV 
nsp1-CD served as negative controls. Intracellular RNAs were extracted at 24 h post-
transfection and subjected to Northern blot analysis using rLuc probe. Expression of 
MERS-CoV nsp1-WT and SARS-CoV nsp1 induced endonucleolytic cleavage of Ren-
EMCV-FF RNA, generating a fast migrating RNA fragment (Fig. 1C, second panel; see 
arrowhead) and reduction in the amounts of the full-length Ren-EMCV-FF RNA (Fig. 1C, 
second panel; see arrow). Consistent with our previous report (43), SARS-CoV nsp1 was 
more active than MERS-CoV nsp1-WT for inducing RNA cleavage. The RNA fragment 
was absent in cells expressing the MERS-CoV nsp1-mt, demonstrating that the MERS-
CoV nsp1-mt lacked the endonucleolytic RNA cleavage activity. Western blat analysis 
confirmed expression of SARS-CoV nsp1, MERS-CoV nsp1-WT, MERS-CoV nsp1-CD, and 
MERS-CoV nsp1-mt in transfected cells (Fig. 1C, fourth panel). Consistent with our 
previous report (43), SARS-CoV nsp1 and MERS-CoV nsp1-WT accumulated poorly in 
expressed cells; these nsp1s probably targeted their own template mRNAs for degra-
dation, leading to poor protein accumulation.
MERS-CoV nsp1-CD, which is deficient for the endonucleolytic RNA cleavage func-
tion (43), suppressed host translation (Fig. 1A), demonstrating that MERS-CoV nsp1-CD 
retained its translational suppression function. The absence of host translation inhibi-
tion in cells expressing MERS-CoV nsp1-mt demonstrated that MERS-CoV nsp1-mt lost 
both the RNA cleavage function and the translation suppression function.
Replication of MERS-CoV mutants encoding mutant nsp1 in Vero cells. To 
explore the role of nsp1 in virus replication and host gene expression, we rescued 
MERS-CoV-WT encoding MERS-CoV nsp1-WT, MERS-CoV-CD carrying MERS-CoV nsp1-
CD, and MERS-CoV-mt carrying MERS-CoV nsp1-mt by using a reverse-genetics system 
(54). All three viruses replicated efficiently with similar replication kinetics in Vero cells 
(Fig. 2A). Also, all of the viruses accumulated similar levels of viral structural proteins, S, 
M, and N, nsp1, and virus-specific mRNAs at each indicated time point (Fig. 2B and C).
Next, we examined the effects of nsp1 for host mRNA stability and host protein 
synthesis in infected Vero cells. The abundance of host GAPDH mRNA was lower in 
MERS-CoV-WT-infected cells than in MERS-CoV-CD- and MERS-CoV-mt-infected cells 
(Fig. 3A). Replication of MERS-CoV-WT, but not the two mutant viruses, in the presence 
of actinomycin D (ActD), also resulted in reduced GAPDH mRNA levels (Fig. 3B, right 
panel), demonstrating that nsp1 induced efficient degradation of preexisting GAPDH 
mRNA in infected cells. Metabolic radiolabeling experiments showed that replication of 
MERS-CoV-WT, as well as the two mutant viruses, induced an inhibition of host protein 
synthesis. (Fig. 3C). Although the extent of host translation inhibition induced by these 
viruses was modest at 24 h postinfection (p.i.), a stronger inhibition of host translation 
was observed in MERS-CoV-WT-infected cells than in those infected with the mutant 
viruses at 32 h p.i., suggesting that the strong inhibition of host gene expression was 
due to a combined effect of the nsp1-mediated RNA cleavage and the translation 
suppression function. Taken together, these data established that nsp1 suppressed host 
gene expression by inducing host mRNA decay and inhibiting host translation in 
infected cells.
Replication of MERS-CoV-WT and the mutant viruses in various cell lines. We 
subsequently examined replication kinetics of the three viruses in various cell lines. All 
of the three viruses replicated efficiently with similar replication kinetics in Calu-3 cells, 
a human airway epithelial cell line (55), regardless of the multiplicity of infections (MOIs)
(Fig. 4A). The three viruses replicated efficiently and similarly at an MOI of 3 in Huh-7 
cells, a well-differentiated hepatocyte-derived cellular carcinoma cell line (56), except 
that the titer of MERS-CoV-WT was statistically 10-fold higher at peak titers than those 
of the mutants at 32 h p.i. (Fig. 4B). In contrast, the two mutant viruses replicated 2 
logs less efficiently than MERS-CoV-WT in Huh-7 cells at an MOI of 0.01 (Fig. 4B). The 
titers of MERS-CoV-WT were statistically higher than those of the mutant viruses from 
24 to 48 h p.i. at an MOI of 3 in 293 cells stably expressing human CD26 (293/CD26 cells)
FIG 2 Growth kinetics of MERS-CoV-WT, -CD, and -mt and accumulation of viral proteins and RNA in infected Vero
cells. (A) Vero cells were infected with MERS-CoV-WT (WT), MERS-CoV-CD (CD), or MERS-CoV-mt (mt) at an MOI of
0.01 (left panel) or 3 (right panel). Culture supernatants were collected at the indicated times, and virus titers were
determined by plaque assay in Vero cells. The results represent the averages of three independent experiments.
Each bar represents the mean ( the standard deviation) for three samples. (B) Vero cells were infected with each
of the three viruses at an MOI of 3. At indicated times postinfection, total proteins were extracted and Western blot
analysis was performed to detect the S, M, N, nsp1, and tubulin by using anti-MERS-CoV S, M, N, nsp1, and tubulin
antibody, respectively. (C) Vero cells were infected with each of the three viruses at an MOI of 3. At the indicated
times, total RNAs were extracted. The viral mRNAs were detected by Northern blotting using a probe that binds
to the 3= end of the MERS-CoV genome. The 28S and 18S rRNAs were detected by ethidium bromide staining.
(Fig. 4C). Likewise, both mutant viruses replicated less efficiently than MERS-CoV-WT in 
293/CD26 cells at an MOI of 0.01. MERS-CoV-WT also replicated to statistically higher 
titers than the two mutants throughout the infection at an MOI of 3 in HeLa cells stably 
expressing CD26 (HeLa/CD26 cells), while both mutants showed similar titers and 
replication kinetics. At an MOI of 0.01 in HeLa/CD26 cells, MERS-CoV-WT replicated to 
higher titers than the mutant viruses after 12 h p.i. Taken together, these data 
suggested that nsp1 promoted virus replication in a cell type-dependent manner.
Replication of the three viruses does not induce IFN- and IFN- mRNAs. To 
determine the mechanisms of nsp1-mediated promotion of virus replication, we used 
293/CD26 cells for subsequent analyses. We first tested the possibility that the mutant 
nsp1 did not suppress the host innate immune responses, thereby promoting produc-
tion of type I IFN and/or III IFN and leading to inhibition of virus replication. To this end,
FIG 3 Effect of replication of MERS-CoV-WT, MERS-CoV-CD, and MERS-CoV-mt on abundance of host 
endogenous mRNA and host protein synthesis in Vero cells. (A and B) Vero cells were either mock 
infected (Mock) or infected with MERS-CoV-WT (WT), MERS-CoV-CD (CD), or MERS-CoV-mt (mt) at an MOI 
of 3. At 16 h p.i. (A) or 24 h p.i. (B, left panel), intracellular RNAs were extracted. For testing host mRNA 
decay in infected cells, ActD was added to the culture at 1 h p.i., and intracellular RNAs were extracted 
at 24 h p.i. (B, right panel). The abundance of GAPDH mRNA was determined using Northern blot analysis 
(top panel). The 28S and 18S rRNAs were detected by ethidium bromide staining (bottom panel). (C) Vero 
cells were either mock infected (Mock) or infected with MERS-CoV-WT (WT), MERS-CoV-CD (CD), or 
MERS-CoV-mt (mt) at an MOI of 3. The cells were radiolabeled for 1 h with Tran35S-label, and cell lysates 
were prepared at the indicated times postinfection. Cell lysates were subjected to SDS-PAGE analysis, 
followed by autoradiography (top panel) and colloidal Coomassie blue staining (bottom panel).
we examined induction of IFN- and IFN- mRNAs in infected 293/CD26 cells (Fig. 5).
Sendai virus (SeV) infection resulted in efficient induction of IFN- and IFN- mRNAs, 
whereas mock-infected cells did not. None of the three viruses efficiently induced IFN-
and IFN- mRNAs from 8 h to 32 h  p.i., suggesting that inefficient replication of 
MERS-CoV-mt and MERS-CoV-CD was not due to induction of type I and III IFNs and that 
the host gene suppression functions of MERS-CoV nsp1 did not play a significant role
in inhibiting the induction of IFN- and IFN- mRNAs in 293/CD26 cells.
Accumulation of viral proteins and mRNAs in infected 293/CD26 cells. To
discern whether inefficient replication of mutant viruses in 293/CD26 cells was due 
to poor accumulation of viral structural proteins, we examined the abundance of
major viral structural proteins, including S, M, and N proteins. No substantial 
differences in the accumulation of these structural proteins were noted among cells
infected with the three viruses (Fig. 6A). The three viruses also accumulated similar
levels of nsp1 (Fig. 6A).
FIG 4 Replication kinetics of MERS-CoV-WT, MERS-CoV-CD, and MERS-CoV-mt in various cell lines. Calu-3 
cells (A), Huh7-cells (B), 293/CD26 cells (C), and HeLa/CD26 cells (D) were infected with MERS-CoV-WT 
(WT), MERS-CoV-CD (CD), or MERS-CoV-mt (mt) at an MOI of 0.01 (left panels) or an MOI of 3 (right 
panels). Culture supernatants were collected at the indicated times, and virus titers were determined by 
plaque assay in Vero cells. The results represent the averages of three independent experiments. Each bar 
represents the mean ( the standard deviation) for three samples. Asterisks represent statically signif-
icant differences between the titers of MERS-CoV-WT and mutant viruses (P  0.05).
Northern blot analysis showed that accumulation of viral mRNAs were marginally 
higher in MERS-CoV-WT-infected cells than in cells infected with the mutant viruses
(Fig. 6B). In addition to eight mRNA species, we noted the presence of two additional 
virus-specific RNA bands; one migrated faster than mRNA 2 and the other migrated 
faster than mRNA 5 in MERS-CoV-mt-infected cells. We also detected another virus-
specific RNA band that migrated between mRNA 5 and mRNAs 6/7 in MERS-CoV-WT-
infected cells at 24 h p.i. The origins of these viral RNAs are currently unclear, yet they
may represent defective RNAs or subgenomic mRNAs. qRT-PCR analyses revealed that 
mRNA 1 of MERS-CoV-WT accumulated higher abundance than that of MERS-CoV-mt at
8 h, 16 h, and 32 h p.i. and that of MERS-CoV-CD at 32 h p.i. In addition, the amount 
of mRNA 8 of MERS-CoV-WT was higher than those of the mutant viruses at 8 and 32 h p.i.
FIG 5 IFN- and IFN- mRNA expression in infected 293/CD26 cells. 293/CD26 cells were either mock 
infected (M) or infected with MERS-CoV-WT (WT), MERS-CoV-CD (CD), or MERS-CoV-mt at an MOI of 3. SeV 
infection (100 HA units) was inoculated as a positive control. Total intracellular RNAs were extracted at 
the indicated times, and the amounts of endogenous IFN- and - mRNA mRNAs were determined by 
qRT-PCR analysis. Expression levels of the genes were normalized to levels of 18S rRNA. Each bar 
represents the mean ( the standard deviation) for three wells.
(Fig. 6C). These studies showed that there was a trend that MERS-CoV-WT accumulated 
higher levels of viral mRNAs than the mutant viruses.
Analyses of host gene expression in infected 293/CD26 cells. The effects of nsp1 
for host mRNA stability and host protein synthesis in infected 293/CD26 cells were 
examined next. Replication of both mutant viruses did not affect abundance of GAPDH 
mRNA, while the abundance of GAPDH mRNA was substantially reduced in MERS-CoV-
WT-infected cells (Fig. 7A), suggesting that MERS-CoV nsp1, but not MERS-CoV nsp1-CD 
and MERS-CoV nsp1-mt, induced degradation of GADPH mRNA in infected cells. 
Metabolic radiolabeling experiments showed that replication of all three viruses in-
duced host protein synthesis inhibition at 24 h p.i. (Fig. 7B). Because MERS-CoV nsp1-mt 
were deficient for the translation inhibition and mRNA cleavage functions (Fig. 1), host 
translational suppression in MERS-CoV-mt-infected cells was independent from the 
nsp1 function. MERS-CoV-WT and MERS-CoV-CD induced slightly stronger host trans-
lational suppression than MERS-CoV-mt at 24 h p.i., suggesting that the translation 
suppression function of the nsp1 modestly contributed to host translation suppression 
in 293/CD26 cells.
Titers of cell-associated virus and abundances of released virus particles 
among the three viruses. MERS-CoV-WT replicated to higher titers than two mutant 
viruses in 293/CD26 cells (Fig. 4C), whereas accumulation of intracellular viral structural 
proteins were comparable among the three viruses (Fig. 6A). One possible interpreta-
tion of these data is that the mutant viruses were able to undergo assembly and 
budding of infectious virus particles as efficient as MERS-CoV-WT, yet the mutant 
viruses were unable to efficiently release infectious viruses from infected cells. If this is 
the case, the titers of the cell-associated viruses would be similar among the three 
viruses. We found that the titers of cell-associated MERS-CoV-WT were higher than 
those of the cell-associated mutant viruses at 24, 36, and 48 h p.i (Fig. 8A). Also, the 
titers of cell-associated MERS-CoV-CD were higher than those of cell-associated MERS-
FIG 6 Accumulation of viral proteins and RNA in infected 293/CD26 cells. (A) 293/CD26 cells were either 
mock infected (Mock) or infected with MERS-CoV-WT (WT), MERS-CoV-CD (CD), or MERS-CoV-mt (mt) at 
an MOI of 3. At indicated times postinfection, total proteins were extracted (A) or total RNAs were 
extracted (B and C). (A) Western blot analysis was performed to detect the S, M, N, nsp1, and tubulin. (B) 
The viral mRNAs were detected by Northern blotting using a probe that binds to the 3= end of the 
MERS-CoV genome, and the 28S and 18S rRNAs were detected by ethidium bromide staining. (C) The 
amounts of genomic RNA and subgenomic mRNA 8 were quantified by qRT-PCR, and expression levels 
were normalized to levels of 18s rRNA. Each bar represents the mean ( the standard deviation) for three 
wells.
CoV-mt at 36 and 48 h p.i. (Fig. 8A). Low titers of cell-free and the cell-associated viruses
(Fig. 4C and 8A) in mutant viruses suggested that the release of infectious viruses was
not selectively inhibited in the mutant viruses. Rather, these data implied that the low 
titers of cell-free viruses in the mutant virus-infected cells were due to the accumulation 
of low titers of cell-associated viruses.
Because soluble CD26 binds to MERS-CoV particles and neutralizes virus infectivity
(57), expressed CD26 might have bound to intracellular virus particles in the mutant 
virus-infected cells, leading to neutralization of the cell-associated virus particles and/or 
preventing virus release. In contrast, MERS-CoV nsp1-WT expression might have effi-
ciently suppressed CD26 expression in MERS-CoV-WT-infected cells, preventing the
putative binding of CD26 to intracellular virus particles. To test a likelihood of this
possibility, we examined the abundance of CD26 in infected cells (Fig. 8B). Although
replication of the three viruses did not affect the levels of CD26 at 24 h p.i., it caused 
a reduction in CD26 abundance at 36 h p.i. There were no substantial differences in the 
amounts of CD26 among MERS-CoV-WT-infected cells and mutant virus-infected cells at
both time points. These data showed that CD26 expression levels did not play signif-
icant roles in low titers of cell-associated and cell-free viruses in the mutant viruses.
FIG 7 Effects of virus replication on GAPDH mRNA level and host protein synthesis in 293/CD26 cells. 
293/CD26 cells were either mock-infected (Mock) or infected with MERS-CoV-WT (WT), MERS-CoV-CD 
(CD), or MERS-CoV-mt (mt) at an MOI of 3. (A) The abundance of GAPDH mRNA at 24 h p.i. was 
determined using Northern blot analysis. The 28S and 18S rRNAs were detected by ethidium bromide 
staining. (B) Cells were radiolabeled for 1 h with Tran35S-label, and cell lysates were prepared at the 
indicated times p.i. Cell lysates were subjected to SDS-PAGE analysis, followed by autoradiography (top 
panel) and colloidal Coomassie blue staining (bottom panel).
Although infection with the mutant viruses produced low titers of infectious viruses, 
it is possible that high levels of noninfectious viruses could have been released into the 
supernatant from the cells infected with the mutant viruses. To test this possibility, we 
examined the amount of virus particles, including both infectious and noninfectious, 
that are released from infected cells. We harvested culture fluid from infected 293/CD26 
cells, inactivated the released viruses by 60Co irradiation, purified the virus particles by 
sucrose gradient centrifugation, and estimated the amounts of the released viruses by 
Western blotting using antibodies detecting S, M, and N proteins. Substantially stronger 
signals of S, M, and N proteins were observed in the purified virus particles obtained 
from MERS-CoV-WT-infected cells showed than in those obtained from mutant virus-
infected cells (Fig. 8C), suggesting that the amounts of virus particles, including both 
infectious and noninfectious virus particles, released from the mutant virus-infected 
cells were lower than those released from MERS-CoV-WT-infected cells. Since virus 
inactivation by gamma irradiation is believed to be mainly caused by radiolytic cleav-
age or cross-linking of genetic material (58–62), we did not examine the amount of viral 
genomic RNA in the purified 60Co-irradiated virus particles.
Transmission electron microscopic analysis of infected 293/CD26 cells. To 
further understand the mechanism of inefficient replication of mutant viruses, we 
performed transmission electron microscopic analysis of infected 293/CD26 cells (Fig. 
9). We observed the accumulation of intracellular virus particles, with the expected 
average size, within intracellular vesicles (Fig. 9A to C). We also noted the presence of 
particles, whose sizes were similar to virus particles, outside these vesicles, and yet the 
identity of these particles was unclear. Because CoV undergoes assembly and budding 
of virus particles at ERGIC membranes (20–22) and then follows the secretory pathway 
for egress (63), these vesicles containing virus particles most probably represented
FIG 8 MERS-CoV-CD and MERS-CoV-mt undergo inefficient virus assembly in 293/CD26 cells. 293/CD26 
cells were infected with MERS-CoV-WT (WT), MERS-CoV-CD (CD), or MERS-CoV-mt (mt) at an MOI of 3. (A) 
At the indicated time points postinfection, the titers of cell-associated viruses were determined by plaque 
assay. The results represent the averages of three independent experiments. Each bar represents the 
mean ( the standard deviation) for three samples. Asterisks represent statically significant differences 
between the titers of MERS-CoV-WT and mutant viruses (P  0.05). Hash marks represent statically 
significant differences between the titers of MERS-CoV-CD and MERS-CoV-mt (P  0.05). (B) At the 
indicated times postinfection, the total proteins were extracted and subjected to Western blot analysis 
using anti-human CD26 or tubulin antibody. Lysate of mock-infected 293 cells was included as a negative 
control in the far right lane of bottom panels. (C) At 36 h p.i., supernatants were collected and subjected 
to 60Co irradiation. The purified viruses were pelleted, dissolved in the same volume of sample buffer, and 
subjected to Western blot analysis by using anti-S, -M, and -N protein antibodies.
those in the secretory pathway. Counting the number of intracellular virus particles in
an arbitrarily selected 30 vesicles for each virus showed the presence of statistically
lower numbers of virus particles within these vesicles inside the cells infected with the
mutant viruses versus MERS-CoV-WT-infected cells (Fig. 9D). However, the number of
virus particles within these virus-containing vesicles between MERS-CoV-CD-infected
cells and MERS-CoV-mt-infected cells showed no statistical difference. These data
suggested that the mutant viruses were less efficient at the production of virus
FIG 9 Transmission electron microscopy of 293/CD26 cells infected with MERS-CoV-WT, -CD, or -mt. 
Ultrastructure analyses of 293/CD26 cells infected with MERS-CoV-WT (A), -CD (B), or -mt (C). Arrowheads 
indicate vesicles containing virus particles. Scale bars, 0.5 m. (D) Numbers of virus particles in randomly 
selected 30 vesicles for each virus sample. Each dot represent the number of virus particles in each 
vesicle. Asterisks represent statically significant differences in virus titers (P  0.05). ns, not significant.
particles, including virus assembly and/or virus budding, than MERS-CoV-WT. Taken 
together, these data support a notion that the mutant viruses were able to accumulate 
viral structural proteins as efficiently as MERS-CoV-WT in 293/CD26 cells (Fig. 6A), 
whereas they were inefficient for assembly or budding of virus particles (Fig. 9). This 
resulted in low titers of cell-associated viruses (Fig. 8A) and the release of a low number 
of virus particles (Fig. 8C), including infectious viruses (Fig. 4C).
As our studies revealed the importance of nsp1 for production of virus particles, we 
also explored the possibility that MERS-CoV nsp1 promotes virus assembly/budding by 
incorporating itself into virus particles. Western blot analysis of purified MERS-CoV-WT, 
MERS-CoV-CD, and MERS-CoV-mt using anti-nsp1 antibody did not show the presence 
of nsp1 in the purified virus particles (data not shown), suggesting that MERS-CoV nsp1 
was not associated with virus particles or was not a major viral protein in the virus 
particles.
DISCUSSION
The present study explored the biological significance of MERS-CoV nsp1 in virus 
replication. By characterizing MERS-CoV nsp1-WT and MERS-CoV nsp-1-CD, the latter of 
which lacked the endonucleolytic RNA cleavage function, our previous study showed 
that expressed MERS-CoV nsp1 suppresses host gene expression by inducing endonu-
cleolytic cleavage of host mRNAs and inhibiting translation, the latter of which is 
independent from the former function (43). SARS-CoV nsp1 also suppresses host gene 
expression by inducing endonucleolytic cleavage of mRNAs and inhibiting translation, 
yet existing data imply that MERS-CoV nsp1 and SARS-CoV nsp1 exert these functions 
by different mechanisms (43). Namely, SARS-CoV nsp1, a cytoplasmic protein (41), binds 
to 40S ribosomal subunits, inactivates translational function of the 40S ribosomes (40),
and induces degradation of host nucleus-derived mRNAs and cytoplasmically synthe-
sized mRNAs (43). In contrast, MERS-CoV nsp1 localizes in both the cytoplasm and the 
nucleus (43), does not bind to 40S ribosomes, and induces the degradation of mRNAs 
of nuclear origin but not those of cytoplasmic origin (43). The present study revealed 
that MERS-CoV nsp1-mt with K181A mutation lost the RNA cleavage and translation 
inhibition functions (Fig. 1). The K181A mutation corresponded to one of the K164A and 
H165A mutations introduced in SARS-CoV nsp1-mt, which also lacks both RNA cleavage 
and translation inhibition functions (46). These data suggest the importance of the 
C-terminal regions of SARS-CoV nsp1 and MERS-CoV nsp1 for the biological functions. 
Because SARS-CoV nsp1-mt is deficient for binding to 40S ribosomes (40), SARS-CoV 
nsp1 probably interacts with the 40S ribosome through its C-terminal region. MERS-
CoV nsp1’s selective biological effects toward nucleus-derived mRNAs led us to hy-
pothesize that MERS-CoV nsp1 targets nucleus-derived mRNAs, by binding to one of 
the mRNA-binding proteins that form the host mRNP complex, and inhibits the 
expression of host genes (43). If this hypothesis is correct, disruption of MERS-CoV 
nsp1’s functions by the K181A mutation imply that the MERS-CoV nsp1 accesses the 
host mRNP complex through its C-terminal region. It is conceivable that both MERS-CoV 
nsp1 and SARS-CoV nsp1 access target host protein/factors through their C-terminal 
regions.
Although MERS-CoV-WT, MERS-CoV-CD, and MERS-CoV-mt replicated efficiently 
with similar growth kinetics in Vero and Calu-3 cells, the two mutant viruses replicated 
less efficiently than MERS-CoV-WT in 293/CD26 cells, Huh-7 cells, and HeLa/CD26 cells 
(Fig. 4). We explored whether induction of type I and/or III IFNs caused inefficient 
replication of the mutant viruses in 293/CD26 cells, which were competent for induc-
tion of IFN- and IFN- mRNAs by SeV infection (Fig. 5). Replication of the three viruses 
did not induce high levels of IFN- and IFN- mRNAs (Fig. 5), demonstrating that 
inefficient replication of the two mutant viruses was not due to induction of the type 
I and III IFNs. It has been reported that MERS-CoV mutant lacking all accessory genes 
induced higher levels of IFN-, IFN-1, and IFN-3 mRNAs than wt MERS-CoV in Calu-3 
2B4 cells (19). Accordingly, it is possible that other viral proteins, including the acces-
sory proteins, suppressed the induction of IFN- and IFN- mRNAs in MERS-CoV-CD-
infected 293/CD26 cells and MERS-CoV-mt-infected 293/CD26 cells. In contrast to 
MERS-CoV, SARS-CoV carrying biological inactive nsp1 induced high levels of IFN- 
mRNA and type I IFN in infected cells (46). These data suggest that MERS-CoV and 
SARS-CoV use different strategies to suppress induction of innate immune responses.
We observed that nsp1-induced changes in translational activities differed between 
infected Vero cells (Fig. 3) and infected 293/CD26 cells (Fig. 7). For each cell line, the 
levels of nsp1 accumulation were similar among the three viruses (Fig. 2B and 6A), 
suggesting that the differences in the functions of nsp1, but not their expression levels, 
affected translational activities. MERS-CoV-WT inhibited translation at 32 h p.i. in Vero 
cells, while the mutant viruses induced modest and similar levels of translational 
inhibition (Fig. 3C), demonstrating that MERS-CoV-nsp1, particularly its RNA cleavage 
function, played a significant role in translational suppression in Vero cells. The mod-
erate level of host translation inhibition in MERS-CoV-mt-infected Vero cells (Fig. 3C) 
could be due to the induction of the cellular stress response to virus infection, which 
is independent of the mode of translation inhibition induced by nsp1. In contrast to 
Vero cells, nsp1 did not play a significant role in virus-induced translation suppression 
in 293/CD26 cells, since the three viruses, including MERS-CoV-mt, efficiently inhibited 
translation at 24 h p.i. (Fig. 7B). These data suggest a cell line-specific effect of 
MERS-CoV nsp1 on host gene expression.
There was a trend of increased viral mRNA accumulation in MERS-CoV-WT-infected 
293/CD26 cells than in mutant virus-infected 293/CD26 cells (Fig. 6B and C), yet the 
differences in the amounts of viral mRNAs did not determine the amount of viral 
proteins (Fig. 6A). As translational activities in 293/CD26 cells infected with MERS-CoV-
WT, -CD, or -mt were similar and lower than that of mock-infected 293/CD26 cells at 24 h 
p.i. (Fig. 7B), low translational activities might have served as a bottle neck, which
allowed translation of only a fraction of viral mRNAs in MERS-CoV-WT-infected 293/
CD26 cells, resulting in similar amounts of viral protein accumulation in the three 
viruses.
We explored the mechanism of inefficient replication of MERS-CoV-CD and MERS-
CoV-mt in 293/CD26 cells. Low titers of cell-associated and cell-free viruses in mutant 
virus-infected cells (Fig. 8 and 4C) were not due to inefficient accumulations of major 
viral structural proteins and nsp1 (Fig. 6). The data showing similar levels of CD26 
expression in 293/CD26 cells infected with the three viruses (Fig. 8B) did not support a 
possibility that MERS-CoV-WT, but not the mutant viruses, inhibited CD26 expression 
and prevented interaction of CD26 with intracellular virus particles, which might have 
induced neutralization of intracellular virus particles and/or inhibition of virus release. 
Electron microscopic analysis showed less efficient intracellular virus particle accumu-
lation in the virus-containing vesicles in mutant virus-infected cells than in MERS-CoV-
WT-infected cells (Fig. 9). These data strongly suggested that low levels of virus particle 
accumulation, which was probably due to inefficient virus assembly/budding, in mu-
tant virus-infected cells caused low titers of cell-associated viruses (Fig. 8A) and cell-free 
viruses (Fig. 8B). The data that MERS-CoV-CD, expressing MERS-CoV nsp1-CD lacking 
the endonucleolytic RNA cleavage function and retaining the translation inhibition 
function, was inefficient for accumulation of intracellular virus particles strongly sug-
gested that the RNA cleavage function of the nsp1 was required for efficient assembly/
budding of MERS-CoV particles. To our knowledge, this is the first demonstration that 
a CoV gene 1 protein affects efficiency of virus assembly.
Several different mechanisms are conceivable for inefficient assembly/budding of 
the two mutant viruses in 293/CD26 cells. One possible mechanism may be that low 
accumulation of E protein, which is known to be important for assembly of many CoVs 
(23, 30, 64), might have occurred in mutant virus-infected cells and prevented efficient 
virus assembly. The absence of appropriate anti-E protein antibodies prevented us from 
directly examining this possibility. However, it seems illogical that the loss of the RNA 
cleavage function of the MERS-CoV nsp1, which did not severely affect the accumula-
tion of S, M, and N proteins (Fig. 6A) and mRNA 6 encoding E protein (Fig. 6B), 
selectively suppressed E protein expression in mutant virus-infected 293/CD26 cells. 
Furthermore, similar translational activities in MERS-CoV-WT- and mutant virus-infected 
293/CD26 cells (Fig. 7B) did not support a possibility of selective inhibition of E protein 
accumulation in the mutant virus-infected 293/CD26 cells. We suspect that E protein 
accumulation was not low in mutant virus-infected 293/CD26 cells.
Another possible mechanism for inefficient assembly of the two mutant viruses 
could be due to lower levels of mRNA 1 accumulation in the mutant virus-infected 
293/CD26 cells (Fig. 6B and C). CoV-like particles are produced from cells expressing 
viral structural proteins in the absence of mRNA 1 (23), yet it is unknown whether mRNA 
1 affects efficiency of CoV particle assembly. There was a trend of higher accumulation 
of mRNA 1 in MERS-CoV-WT-infected 293/CD26 cells than in mutant virus-infected 
293/CD26 cells (Fig. 6C). If mRNA 1 promotes the assembly of CoV particles, reduced 
amounts of mRNA 1 would have caused inefficient virus assembly in mutant virus-
infected 293/CD26 cells. Another possibility of the inefficient assembly/budding of the 
two mutant viruses would be that MERS-CoV-nsp1-WT, but not MERS-CoV-nsp1-CD and 
MERS-CoV-nsp1-mt, suppressed expression of a host protein that restricts assembly/
budding of MERS-CoV particles. Although host translation was inhibited to similar levels 
between MERS-CoV-WT-infected 293/CD26 cells and MERS-CoV-CD-infected 293/CD26 
cells (Fig. 7B), the RNA cleavage function of the MERS-CoV nsp1-WT might have 
induced efficient degradation of the mRNA encoding this putative virus assembly/
budding restriction protein, preventing the accumulation of this putative protein and 
promoting virus assembly/budding in MERS-CoV-WT-infected 293/CD26 cells. In con-
trast, due to lack of the RNA cleavage function in MERS-CoV-nsp1-CD and MERS-CoV-
nsp1-mt, this putative host protein might have been expressed abundantly in mutant 
virus-infected 293/CD26 cells, preventing efficient virus assembly. If this possibility is 
the case, a plausible reason for the efficient replication of mutant viruses in Vero and
Calu-3 cells may be that these cells express the putative virus restriction protein at low
levels, the amounts of which are not sufficient for inhibiting MERS-CoV assembly/
budding. Tetherin has been known as a host restriction factor capable of impeding the
release of multiple viruses, including CoV (65–69). Because tetherin primarily prevents
release of viruses from the cells, but does not affect virus assembly/budding, this
putative virus-assembly restriction protein may not be tetherin.
Viral proteins that inhibit host gene expression, including nsp1 of CoV (49–51), are
often major virulence factors (70–79). Accordingly, it is likely that MERS-CoV nsp1 also
plays a critical role in MERS-CoV pathogenesis. Because MERS-CoV nsp1-CD and MERS-
CoV nsp1-mt negatively affected the efficient production of infectious viruses in several
human cell lines, MERS-CoV-CD and MERS-CoV-mt could exhibit a reduced virulence in
infected hosts, compared to MERS-CoV-WT, at least partly due to the inefficient
production of infectious viruses. Further studies are warranted, including a detailed
characterization of the replication and virulence of MERS-CoV-WT, MERS-CoV-CD, and
MERS-CoV-mt in animal models (80–83), to clarify the role of nsp1 in MERS-CoV
pathogenicity.
Herpes simplex virus 1 and 2 virion host shutoff protein, Kaposi’s sarcoma-
associated herpesvirus SOX, and influenza A virus PA-X are virus-encoded RNases that
induce endonucleolytic cleavage of host mRNAs, leading to host mRNA degradation
(84, 85). These viral endonucleases contribute to evasion of host antiviral responses,
including IFN response and stress granule formation, and contribute to viral pathogen-
esis (70–79), while roles of these virus-encoded endonucleases in production of virus
particle have not been explored. To our knowledge, MERS-CoV nsp1 represents the first
viral protein whose RNA cleavage-inducing function promotes virus assembly/budding.
MATERIALS AND METHODS
Cells. Vero cells (ATCC number CCL-81), Calu-3 cells, and Huh-7 cells were maintained in minimum 
essential medium supplemented with 10% fetal calf serum (FBS), GlutaMAX (Gibco) supplemented with 
10% FBS, and Dulbecco modified Eagle medium supplemented plus 10% FBS, respectively. HeLa/CD26 
cells were generated as described in a previous report (43). Briefly, HeLa cells were transfected with 
pCAGGS-CD26-BlasticidinR and grown in selection medium containing blasticidin (10 g/ml) for 2 weeks. 
293/CD26 cells were generated by transfecting pCAGGS-CD26-BlasticidinR into 293 cells (ATCC) and 
subsequent incubation of the transfected cells in the presence of blasticidin (12 g/ml). Stable expres-
sion of human CD26 in 293/CD26 and HeLa/CD26 cells was confirmed by Western blotting with 
anti-human DPP4 antibody (R&D Systems).
Viruses. MERS-CoV-WT, MERS-CoV-CD, and MERS-CoV-mt were rescued by using reverse-genetics 
system as reported previously (54). All virus strains were passaged once in Vero cells and used for 
infection studies. The presence of the expected mutation and absence of other mutations in nsp1 was 
confirmed prior to use of these viruses. For virus growth analysis, Vero, Calu-3, Huh-7, HeLa/CD26, and 
293/CD26 cells were infected with MERS-CoV-WT, -CD, or -mt at an MOI of 3 or 0.01. After virus 
adsorption for 1 h at  37°C, the cells were washed twice with phosphate-buffered saline (PBS) and 
incubated with the appropriate medium. The culture fluid was collected at indicated time points, and the 
infectious virus titers were determined by plaque assay on Vero cells. All experiments with infectious 
MERS-CoV were performed in an approved biosafety level 3 laboratory at The University of Texas Medical 
Branch at Galveston. Cantell strain of SeV was obtained from Charles River Laboratory (Wilmington, MA) 
and was used to infect cells at 100 hemagglutination (HA) unit/ml. Viral stocks were prepared in Vero 
cells and stored at 80°C.
Plasmids. pCAGGA-based expression plasmids, pCAGGS-CAT, -SARS-CoV nsp1, -MERS-CoV nsp1-WT, 
and -MERS-CoV nsp1-CD, all of which carried a C-terminal myc tag, were described previously (43). 
pCAGGS-MERS-CoV nsp1-mt, expressing a C-terminal myc-tagged MERS-CoV nsp1 carrying a Lys-to-Ala 
substitution at position 181, was generated from pCAGGS-MERS-CoV nsp1 by using a recombinant 
PCR-based method. Sequence analysis of the plasmid confirmed the presence of the expected nsp1 
sequence. pRL-EMCV-FL expressing a bicistronic reporter mRNA carrying the EMCV IRES between the 
upstream rLuc gene and the downstream fLuc gene was used (43).
Northern blot analysis. Subconfluent 293 cells were transfected with a plasmid encoding CAT, 
SARS-CoV nsp1, MERS-CoV nsp1-WT, -CD, or -mt, together with pRL-EMCV-FL. At 24 h posttransfection, 
total RNAs were extracted and subjected to Northern blot analysis with an rLuc probe and a GAPDH 
probe. Northern blot analysis was performed as described previously (43). Vero and 293/CD26 cells were 
infected with MERS-CoV-WT, MERS-CoV-CD, or MERS-CoV-mt at an MOI of 3. At the indicated times 
postinfection, the total RNAs were extracted and subjected to Northern blot analysis with GAPDH probe. 
To detect MERS-CoV mRNAs, a digoxigenin-labeled random-primed probe corresponding to nucleotides 
29084 to 29608 of the MERS-CoV genome were used.
Metabolic radiolabeling of intracellular proteins. Subconfluent 293 cells were transfected with in 
vitro-synthesized capped and polyadenylated RNA transcripts encoding CAT, SARS-CoV nsp1, MERS-CoV
nsp1-WT, MERS-CoV nsp1-CD, or MERS-CoV nsp1-mt. All encoded proteins carried the C-terminal myc 
tag. After incubation in methionine-deficient medium for 30 min, the cells were metabolically labeled 
with 20 Ci of Tran35S-label (1,000 Ci/mmol; Perkin-Elmer)/ml from 8.5 to 9.5 h posttransfection. Infected 
Vero cells were radiolabeled with 75 Ci of Tran35S-label/ml for 1 h at 16 or 24 h  p.i. The cell extracts were 
prepared by lysing the cells in SDS-PAGE sample buffer. Cell lysates were subjected to SDS-PAGE analysis, 
followed by autoradiography and colloidal Coomassie blue staining.
Western blot analysis. Antibodies for MERS-CoV proteins were generated by immunizing rabbits 
with the following synthetic peptides: NDITNTNLSRGRGRNPKPR for anti-MERS-CoV N protein peptide 
antibody, DDRTEVPQLVNANQYSPCVSIVC for anti-MERS-CoV S protein peptide antibody, and CDYDRLP 
NEVTVAK for anti-MERS-CoV M protein peptide antibody. Anti-MERS-CoV nsp1 antibody was generated 
by immunizing rabbits with purified C-terminal His-tagged MERS-CoV nsp1. Vero and 293/CD26 cells 
were infected with MERS-CoV-WT, MERS-CoV-CD, or MERS-CoV-mt at an MOI of 3. At the indicated time 
points, whole-cell lysates were prepared and subjected to Western blot analysis as described previously 
(43). Anti-myc antibody (Millipore), anti-tubulin antibody (Calbiochem), or antibodies against each of 
MERS-CoV protein described above were used as primary antibodies. Goat anti-mouse immunoglobulin 
G– horseradish peroxidase or goat anti-rabbit immunoglobulin G– horseradish peroxidase (Santa Cruz) 
were used as secondary antibodies.
Total RNA extraction and qRT-PCR. Total cellular RNAs were extracted from virus-infected cells by 
using TRIzol LS reagent (Invitrogen) and Direct-zol RNA MiniPrep (Zymo Research), according to the 
instruction manuals. cDNAs were synthesized using SuperScript III reverse transcriptase (Invitrogen) and 
random primers (Invitrogen). To specifically detect MERS-CoV genomic or subgenomic RNAs, cDNAs were 
synthesized by using a MERS-CoV gene-specific primer (5=-TTTTTTTTCTAATCAGTGTTAACATCAATCATTG 
G-3=). qRT-PCR was performed using a Bio-Rad CFX96 real-time PCR apparatus and SYBR green Master 
mix (Bio-Rad). The PCR conditions were as follows: preincubation at 95°C for 30 s and amplification with 
40 cycles of 95°C for 15 s and 60°C for 20 s. The purity of the amplified PCR products was confirmed by 
the dissociation melting curves obtained after each reaction. The primers used for human IFN- mRNA 
were 5=-AAGGCCAAGGAGTACAGTC-3= (forward) and 5=-ATCTTCAGTTTVGGAGGTAA-3= (reverse), the 
primers used for IFN- mRNA were 5=-CGCCTTGGAAGAGTCACTCA-3= (forward) and 5=-GAAGCCTCAGGT 
CCCAATTC-3= (reverse), the primers used for 18S rRNA were 5=-CCGGTACAGTGAAACTGCGAATG-3= 
(forward) and 5=-GTTATCCAAGTAGGAGAGGAGCGAG-3= (reverse), the primers used for MERS-CoV 
genomic RNA/mRNA 1 were 5=-AATACACGGTTTCGTCCGGTG-3= (forward) and 5=-ACCACAGAGTGGCACA 
GTTAG-3= (reverse), and the primers used for MERS-CoV subgenomic RNA 8 were 5=-CTCGTTCTCTTGCA 
GAACTTTG-3= (forward) and 5=-TGCCCAGGTGGAAAGGT-3= (reverse). The relative expression level of each 
gene mRNA were normalized to 18S rRNA levels. All of the assays were performed in triplicate, and the 
results are expressed as means  the standard deviations.
Titration of intracellular infectious particles in infected 293/CD26 cells. At the indicated times 
postinfection, infected 293/CD26 cells were washed two times in PBS and pelleted by centrifugation at 
3,000 rpm for 10 min. The pelleted cells were suspended in growth medium and lysed by three 
freeze-thaw cycles. After centrifugation at 3,000 rpm for 10 min, supernatant was collected and subjected 
to plaque assays using Vero cells.
Purification of released virus particles. After centrifugation at 1,500  g for 10 min at 4°C, 
supernatants from 293/CD26 cells infected with MERS-CoV-WT, -CD or –mt were irradiated with 2  106 
rads from a Gammacell 60Co source (model 109A; J. L. Shepherd and Associates, San Fernando, CA) to 
completely inactivate viruses. Inactivation of virus infectivity was confirmed by blind passages on the 
samples in Vero cells two times. The inactivated samples were applied onto a discontinuous sucrose 
gradient consisted of 20, 30, 50, and 60% sucrose in NTE buffer (100 mM NaCl, 10 mM Tris-HCl [pH 7.5], 
1 mM EDTA) and subjected to centrifugation at 26,000 rpm for 3 h in an SW28 rotor. The virus particles 
in the interface of 50 to 30% fraction were collected, diluted with NTE buffer, applied onto a discontin-
uous sucrose gradient, and centrifuged at 26,000 rpm for 18 h in an SW28 rotor. After collecting the 
purified MERS-CoV particle in the interface of 50 to 30% sucrose, MERS-CoV particles were pelleted by 
centrifugation at 38,000 rpm for 2 h using a Beckman SW41 rotor. The purified virus particles in the 
pellets were dissolved in the same amount of 1 SDS sample buffer and subjected to Western blot 
analysis.
Electron microscopic analysis. Monolayer 293/CD26 cells were infected with MERS-CoV-WT, -CD, or 
-mt at an MOI of 3. At 36 h p.i., the cells were washed with PBS and fixed with 4% formaldehyde and 0.1%
glutaraldehyde in 0.05 M cacodylate buffer (pH 7.3), to which 0.03% picric acid and 0.03% CaCl2 were 
added. The monolayers were washed in 0.1 M cacodylate buffer, and the cells were scraped off and 
processed further as a pellet. The pellets were postfixed in 1% OsO4 in 0.1 M cacodylate buffer (pH 7.3) 
for 1 h, washed with distilled water, and en bloc stained with 2% aqueous uranyl acetate for 20 min at 
60°C. The pellets were dehydrated in ethanol, processed through propylene oxide, and embedded in 
Poly/Bed 812 (Polysciences). Ultrathin sections were cut on Leica EM UC7 ultramicrotome (Leica Micro-
systems, Buffalo Grove, IL), stained with lead citrate, and examined with a CM-100 electron microscope 
at 60 kV.
Statistical analysis. One-way analysis of variance with Tukey’s multiple-comparison test was con-
ducted to determine statistical significance. A P value of 0.05 was considered statistically significant.
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